DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for orofacial cleft 11 — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleOrofacial cleft 11 maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for orofacial cleft 11 is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
A 2012 systematic review of cleft lip and palate treatment found only 28 randomised controlled trials adequate to guide clinical practice out of 170 articles identified. The experimental approaches examined in those trials were infant orthopedics, rectal acetaminophen, palatal block with bupivacaine, infraorbital nerve block with bupivacaine, osteogenesis distraction, intravenous dexamethasone sodium phosphate, and alveoloplasty with bone morphogenetic protein-2. The review concluded that few RCTs exist, especially on surgical repair, and called for more multicentre collaborations to reduce treatment variability and ensure evidence-based practice.
A 2015 review of hedgehog signaling in upper lip formation states that Shh signaling is indispensable for normal embryonic development and that its disruption can cause a wide spectrum of craniofacial disorders including cleft lip. The review also notes that despite various proposed mechanisms, a detailed bridging of individual signaling pathways to cleft lip remains elusive. A 2021 case report from the perspective of a patient with unilateral cleft lip and palate describes the long-term, multidisciplinary management required from birth into adulthood, involving staged surgical and non-surgical interventions for hearing, speech, occlusion and facial aesthetics, and emphasises the heavy burden of care and psychosocial challenges.
A 2010 Czech paper describes orthodontic treatment as an integral part of the treatment protocol for orofacial cleft patients, coordinated with surgical reconstruction of the midface within specialised cleft centres in Prague and Brno. No drug treatment for orofacial cleft 11 specifically is mentioned in any of these abstracts. What remains missing are randomised trials directly testing any pharmacological intervention for this specific cleft subtype, and any molecular or genetic stratification that might identify patients who could benefit from a targeted therapy.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Plastic Surgery International · 2012 · 96 citations · open access
Protocols in Cleft Lip and Palate Treatment: Systematic Review
AbstractObjectives. To find clinical decisions on cleft treatment based on randomized controlled trials (RCTs). Method. Searches were made in PubMed, Embase, and Cochrane Library on cleft lip and/or palate. From the 170 articles found in the searches, 28 were considered adequate to guide clinical practice. Results. A scarce number of RCTs were found approaching cleft treatment. The experimental clinical approaches analyzed in the 28 articles were infant orthopedics, rectal acetaminophen, palatal block with bupivacaine, infraorbital nerve block with bupivacaine, osteogenesis distraction, intravenous dexamethasone sodium phosphate, and alveoloplasty with bone morphogenetic protein-2 (BMP-2). Conclusions. Few randomized controlled trials were found approaching cleft treatment, and fewer related to surgical repair of this deformity. So there is a need for more multicenter collaborations, mainly on surgical area, to reduce the variety of treatment modalities and to ensure that the cleft patient receives an evidence-based clinical practice.
BioMed Research International · 2015 · 37 citations · open access
The Roles of Hedgehog Signaling in Upper Lip Formation
AbstractCraniofacial development consists of a highly complex sequence of the orchestrated growth and fusion of facial processes. It is also known that craniofacial abnormalities can be detected in 1/3 of all patients with congenital diseases. Within the various craniofacial abnormalities, orofacial clefting is one of the most common phenotypic outcomes associated with retarded facial growth or fusion. Cleft lip is one of the representative and frequently encountered conditions in the spectrum of orofacial clefting. Despite various mechanisms or signaling pathways that have been proposed to be the cause of cleft lip, a detailed mechanism that bridges individual signaling pathways to the cleft lip is still elusive. Shh signaling is indispensable for normal embryonic development, and disruption can result in a wide spectrum of craniofacial disorders, including cleft lip. This review focuses on the current knowledge about the mechanisms of facial development and the etiology of cleft lip that are related to Shh signaling.
BMJ Case Reports · 2021 · 3 citations · open access
Long-term treatment outcomes from the perspective of a patient with unilateral cleft lip and palate
AbstractThe management of patients with orofacial cleft (OFC) often extends from diagnosis or birth well into adulthood and requires many different specialists within multidisciplinary teams (MDT). The aims of treatment are to restore form and function relating to hearing, speech, occlusion and facial aesthetics. People with OFCs that include the lip, alveolus and palate (cleft lip and palate (CLP)) require several different staged and coordinated surgical and non-surgical interventions, and the treatment pathway is associated with a heavy burden of care. Due to the extensive nature of the interaction with these patients, MDT members have opportunities to provide enhanced patient-centred care and support. This case report provides an overview of the current knowledge of the aetiology of OFC and the management of these patients. It provides a unique perspective from one of the coauthors who has a unilateral CLP (UCLP) and reports on his treatment experiences and long-term treatment outcomes. By having a better understanding of the impact of UCLP and treatment provided, MDT members can not only provide improved clinical treatment but also offer improved patient experiences for those with craniofacial anomalies, in particular, an increased awareness of the psychosocial challenges, they endure throughout their treatment pathway and beyond.
Česká stomatologie a praktické zubní lékařství · 2010 · 1 citations · open access
Orthodontic Treatment of a Patient with Facial Cleft (Part 1)
AbstractCĂlem lĂŠÄby pacientĹŻ postiĹženĂ˝ch rozĹĄtÄpem v orofaciĂĄlnĂ oblasti je funkÄnĂ a estetickĂĄ rehabilitace mÄkkĂ˝ch tkĂĄnĂ obliÄeje, defektu Äelisti a dentice. Na komplexnĂ lĂŠÄbÄ se v zĂĄvislosti na typu a rozsahu defektu, postnatĂĄlnĂm vĂ˝voji a zdravotnĂm stavu postiĹženĂŠho dĂtÄte podĂlĂ tĂ˝m specialistĹŻ, jehoĹž interdisciplinĂĄrnĂ pĂŠÄe je soustĹedÄna do specializovanĂ˝ch rozĹĄtÄpovĂ˝ch center. V ÄeskĂŠ republice majĂ dlouholetou tradici pracoviĹĄtÄ v Praze a v BrnÄ. NedĂlnou souÄĂĄstĂ lĂŠÄebnĂŠho protokolu je ortodontickĂĄ terapie. NĂĄsledujĂcĂ sdÄlenĂ je shrnutĂm nejdĹŻleĹžitÄjĹĄĂch fĂĄzĂ ortodontickĂŠ lĂŠÄby v nĂĄvaznosti na chirurgickĂŠ rekonstrukce stĹednĂ obliÄejovĂŠ etĂĄĹže.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
